Nucleic Acids Research, 1989, Vol. 17, No. 9 3551-3561
© 1989
MOLECULAR BIOLOGY |
Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis
Institute for Molecular Virology, St Louis University School of Medicine 3681 Park Avenue, St Louis, MO 63110 1Retroviruses Branch and AIDS Program, Center for Disease Control Atlanta, GA 30333, USA
*To whom correspondence should be addresse
Received December 20, 1988. Revised March 31, 1989. Accepted March 31, 1989.
The tat gene of HIV-1 is a potent trans-activator of gene expression from the HIV long terminal repeat (LTR). To define the functionally important regions of the product of the tat gene (Tat) of HIV-1, deletion, linker insertion and single amino acid substitution mutants within the Tat coding region of strain SF2 were constructed. The effect of these mutations on trans-activation was assessed by measuring the expression of the bacterial chloramphenicol acetyltransferase (CAT) reporter gene linked to the HIV-LTR. These studies have revealed that four different domains of the protein that map within the N-terminal 56 amino acid region are essential for Tat function. In addition to the essential domains, an auxiliary domain that enhances the activity of the essential region has also been mapped between amino acid residues 58 and 66. One of the essential domains maps in the N-terminal 20 amino acid region. The other three essential domains are highly conserved among the various strains of HIV-1 and HIV-2 as well as simian immunodeficiency virus (SIV). Of the conserved domains, one contains seven Cys residues and single amino acid substitutions for several Cys residues indicate that they are essential for Tat function. The second conserved domain contains a Lys X Leu Gly Ile X Tyr motif in which the Lys residue is essential for trans-activation and the other residues are partially essential. The third conserved domain is strongly basic and appears to play a dual role. Mutants lacking this domain are deficient in trans-activation and in efficient targeting of Tat to the nucleus and nucleolus. The combination of the four essential domains and the auxiliary domain contribute to the near full activity observed with the 101 amino acid Tat protein.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Kuciak, C. Gabus, R. Ivanyi-Nagy, K. Semrad, R. Storchak, O. Chaloin, S. Muller, Y. Mely, and J.-L. Darlix The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro Nucleic Acids Res., June 1, 2008; 36(10): 3389 - 3400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shojania and J. D. O'Neil HIV-1 Tat Is a Natively Unfolded Protein: THE SOLUTION CONFORMATION AND DYNAMICS OF REDUCED HIV-1 Tat-(1-72) BY NMR SPECTROSCOPY J. Biol. Chem., March 31, 2006; 281(13): 8347 - 8356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Desfosses, M. Solis, Q. Sun, N. Grandvaux, C. Van Lint, A. Burny, A. Gatignol, M. A. Wainberg, R. Lin, and J. Hiscott Regulation of Human Immunodeficiency Virus Type 1 Gene Expression by Clade-Specific Tat Proteins J. Virol., July 15, 2005; 79(14): 9180 - 9191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Ruckwardt, I. Tikhonov, S. Berg, G. S. Hatfield, A. Chandra, P. Chandra, B. Gilliam, R. R. Redfield, R. C. Gallo, and C. D. Pauza Sequence Variation within the Dominant Amino Terminus Epitope Affects Antibody Binding and Neutralization of Human Immunodeficiency Virus Type 1 Tat Protein J. Virol., December 1, 2004; 78(23): 13190 - 13196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Campbell, E. Pasquier, J. Watkins, V. Bourgarel-Rey, V. Peyrot, D. Esquieu, P. Barbier, J. de Mareuil, D. Braguer, P. Kaleebu, et al. The Glutamine-rich Region of the HIV-1 Tat Protein Is Involved in T-cell Apoptosis J. Biol. Chem., November 12, 2004; 279(46): 48197 - 48204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hwang, N. Tamilarasu, K. Kibler, H. Cao, A. Ali, Y.-H. Ping, K.-T. Jeang, and T. M. Rana Discovery of a Small Molecule Tat-trans-Activation-responsive RNA Antagonist That Potently Inhibits Human Immunodeficiency Virus-1 Replication J. Biol. Chem., October 3, 2003; 278(40): 39092 - 39103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yang, B. Dong, P. R. Mittelstadt, H. Xiao, and J. D. Ashwell HIV Tat Binds Egr Proteins and Enhances Egr-dependent Transactivation of the Fas Ligand Promoter J. Biol. Chem., May 24, 2002; 277(22): 19482 - 19487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kameoka, M. Morgan, M. Binette, R. S. Russell, L. Rong, X. Guo, A. Mouland, L. Kleiman, C. Liang, and M. A. Wainberg The Tat Protein of Human Immunodeficiency Virus Type 1 (HIV-1) Can Promote Placement of tRNA Primer onto Viral RNA and Suppress Later DNA Polymerization in HIV-1 Reverse Transcription J. Virol., March 19, 2002; 76(8): 3637 - 3645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Bogerd, H. L. Wiegand, P. D. Bieniasz, and B. R. Cullen Functional Differences between Human and Bovine Immunodeficiency Virus Tat Transcription Factors J. Virol., May 15, 2000; 74(10): 4666 - 4671. [Abstract] [Full Text]
|
|
|
|
|
|
S. Mitola, R. Soldi, I. Zanon, L. Barra, M. I. Gutierrez, B. Berkhout, M. Giacca, and F. Bussolino Identification of Specific Molecular Structures of Human Immunodeficiency Virus Type 1 Tat Relevant for Its Biological Effects on Vascular Endothelial Cells J. Virol., January 1, 2000; 74(1): 344 - 353. [Abstract] [Full Text]
|
|
|
|
|
|
K.-T. Jeang, H. Xiao, and E. A. Rich Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat J. Biol. Chem., October 8, 1999; 274(41): 28837 - 28840. [Full Text] [PDF]
|
|
|
|
|
|
P. D. Bieniasz, T. A. Grdina, H. P. Bogerd, and B. R. Cullen Analysis of the Effect of Natural Sequence Variation in Tat and in Cyclin T on the Formation and RNA Binding Properties of Tat-Cyclin T Complexes J. Virol., July 1, 1999; 73(7): 5777 - 5786. [Abstract] [Full Text]
|
|
|
|
|
|
K. Verhoef and B. Berkhout A Second-Site Mutation That Restores Replication of a Tat-Defective Human Immunodeficiency Virus J. Virol., April 1, 1999; 73(4): 2781 - 2789. [Abstract] [Full Text]
|
|
|
|
|
|
S. R. Bartz and M. Emerman Human Immunodeficiency Virus Type 1 Tat Induces Apoptosis and Increases Sensitivity to Apoptotic Signals by Up-Regulating FLICE/Caspase-8 J. Virol., March 1, 1999; 73(3): 1956 - 1963. [Abstract] [Full Text]
|
|
|
|
|
|
H. Chen, G. Wilcox, G. Kertayadnya, and C. Wood Characterization of the Jembrana Disease Virus tat Gene and the cis- and trans-Regulatory Elements in Its Long Terminal Repeats J. Virol., January 1, 1999; 73(1): 658 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. El Kharroubi, G. Piras, R. Zensen, and M. A. Martin Transcriptional Activation of the Integrated Chromatin-Associated Human Immunodeficiency Virus Type 1 Promoter Mol. Cell. Biol., May 1, 1998; 18(5): 2535 - 2544. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. P. Cujec, H. Okamoto, K. Fujinaga, J. Meyer, H. Chamberlin, D. O. Morgan, and B. M. Peterlin The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II Genes & Dev., October 15, 1997; 11(20): 2645 - 2657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Gregoire and E. P. Loret Conformational Heterogeneity in Two Regions of TAT Results in Structural Variations of This Protein as a Function of HIV-1 Isolates J. Biol. Chem., September 13, 1996; 271(37): 22641 - 22646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu, Z. Wang, and T. M. Rana Visualizing a Specific Contact in the HIV-1 Tat Protein Fragment and trans-Activation Responsive Region RNA Complex by Photocross-linking J. Biol. Chem., April 26, 1996; 271(17): 10391 - 10396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C D Southgate and M R Green The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes & Dev., December 1, 1991; 5(12b): 2496 - 2507. [Abstract] [PDF]
|
|
|
|
|
|
B J Calnan, S Biancalana, D Hudson, and A D Frankel Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition. Genes & Dev., February 1, 1991; 5(2): 201 - 210. [Abstract] [PDF]
|
|
|
|
|
|
S Roy, U Delling, C H Chen, C A Rosen, and N Sonenberg A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. Genes & Dev., August 1, 1990; 4(8): 1365 - 1373. [Abstract] [PDF]
|
|
|
|
|
|
Y.-H. Ping and T. M. Rana DSIF and NELF Interact with RNA Polymerase II Elongation Complex and HIV-1 Tat Stimulates P-TEFb-mediated Phosphorylation of RNA Polymerase II and DSIF during Transcription Elongation J. Biol. Chem., April 13, 2001; 276(16): 12951 - 12958. [Abstract] [Full Text] [PDF]
|
|